Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Inclusion Criteria:

• Men and women ≥ 18 years of age;

• Clinical diagnosis of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE);

• Anticoagulant treatment completed

• No recurrence of Venous Thromboembolism (VTE)

Exclusion Criteria:

• Subjects with indications for long-term treatment with a vitamin K antagonist

• Active bleeding or high risk for serious bleeding

• Short life expectancy

• Uncontrolled high blood pressure

• Impaired kidney or liver function